Shaker Financial Services LLC bought a new stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 48,817 shares of the company’s stock, valued at approximately $703,000.
A number of other hedge funds have also made changes to their positions in the business. Estabrook Capital Management purchased a new position in BlackRock Health Sciences Term Trust in the 4th quarter worth approximately $35,000. Blue Bell Private Wealth Management LLC boosted its stake in shares of BlackRock Health Sciences Term Trust by 1.8% in the fourth quarter. Blue Bell Private Wealth Management LLC now owns 186,084 shares of the company’s stock valued at $2,680,000 after purchasing an additional 3,352 shares during the period. Commonwealth Equity Services LLC grew its holdings in BlackRock Health Sciences Term Trust by 3.7% during the 4th quarter. Commonwealth Equity Services LLC now owns 102,437 shares of the company’s stock valued at $1,475,000 after purchasing an additional 3,635 shares in the last quarter. Corient Private Wealth LLC increased its stake in BlackRock Health Sciences Term Trust by 24.9% during the 4th quarter. Corient Private Wealth LLC now owns 26,225 shares of the company’s stock worth $378,000 after buying an additional 5,224 shares during the period. Finally, Brown Lisle Cummings Inc. lifted its holdings in BlackRock Health Sciences Term Trust by 17.0% in the 4th quarter. Brown Lisle Cummings Inc. now owns 42,711 shares of the company’s stock worth $615,000 after buying an additional 6,198 shares in the last quarter.
BlackRock Health Sciences Term Trust Stock Performance
Shares of BlackRock Health Sciences Term Trust stock opened at $13.45 on Tuesday. BlackRock Health Sciences Term Trust has a 1-year low of $12.58 and a 1-year high of $16.75. The business has a 50-day moving average of $14.91 and a 200-day moving average of $15.34.
BlackRock Health Sciences Term Trust Cuts Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Term Trust
- How to Buy Gold Stock and Invest in Gold
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- What is a Special Dividend?
- Why Call Option Traders Are Targeting This Dividend ETF Now
- How to Short Nasdaq: An Easy-to-Follow Guide
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.